Showing results 3 to 9 of 9
< previous
| Issue Date | Title | Author(s) |
| 2020-10 | Is multileaf collimator tracking or gating a better intrafraction motion adaptation strategy? An analysis of the TROG 15.01 stereotactic prostate ablative radiotherapy with KIM (SPARK) trial. | Hewson, EA; Nguyen, DT; O'Brien, R; Poulsen, PR; Booth, JT; Greer, P; Eade, T; Kneebone, A; Hruby, G; Moodie, T; Hayden, AJ; Turner, SL; Hardcastle, N; Siva, S; Tai, KH; Martin, J; Keall, PJ |
| 2020-11-03 | MLC tracking for lung SABR is feasible, efficient and delivers high-precision target dose and lower normal tissue dose. | Booth, J; Caillet, V; Briggs, A; Hardcastle, N; Angelis, G; Jayamanne, D; Shepherd, M; Podreka, A; Szymura, K; Nguyen, DT; Poulsen, P; O'Brien, R; Harris, B; Haddad, C; Eade, T; Keall, P |
| 2016-03-04 | A randomised phase II trial of Stereotactic Ablative Fractionated radiotherapy versus Radiosurgery for Oligometastatic Neoplasia to the lung (TROG 13.01 SAFRON II) | Siva, S; Kron, T; Bressel, M; Haas, M; Mai, T; Vinod, S; Sasso, G; Wong, W; Le, H; Eade, T; Hardcastle, N; Chesson, B; Pham, D; Høyer, M; Montgomery, R; Ball, D |
| 2020-07 | Real-Time Image Guided Ablative Prostate Cancer Radiation Therapy: Results From the TROG 15.01 SPARK Trial. | Keall, P; Nguyen, DT; O'Brien, R; Hewson, E; Ball, H; Poulsen, P; Booth, J; Greer, P; Hunter, P; Wilton, L; Bromley, R; Kipritidis, J; Eade, T; Kneebone, A; Hruby, G; Moodie, T; Hayden, A; Turner, S; Arumugam, S; Sidhom, M; Hardcastle, N; Siva, S; Tai, K-H; Gebski, V; Martin, J |
| 2021-08-29 | Single-Fraction vs Multifraction Stereotactic Ablative Body Radiotherapy for Pulmonary Oligometastases (SAFRON II) | Siva, S; Bressel, M; Mai, T; Le, H; Vinod, S; de Silva, H; Macdonald, S; Skala, M; Hardcastle, N; Rezo, A; Pryor, D; Gill, S; Higgs, B; Wagenfuehr, K; Montgomery, R; Awad, R; Chesson, B; Eade, T; Wong, W; Sasso, G; De Abreu Lourenco, R; Kron, T; Ball, D; Neeson, P; Bettington, C; Cook, O; Foote, M; Gowda, R; Haas, M; Haynes, NM; Hilder, B; Lao, L; Lim, A; Ludbrook, J; Jansen, T; MacManus, M; McCullough, SA; Moore, A; Ritchie, D; Shaw, M; Sia, J; Syed, F; Tang, C; Trapani, J |
| 2021-05-03 | Study protocol of the LARK (TROG 17.03) clinical trial: a phase II trial investigating the dosimetric impact of Liver Ablative Radiotherapy using Kilovoltage intrafraction monitoring | Lee, YYD; Nguyen, DT; Moodie, T; O’Brien, R; McMaster, A; Hickey, A; Pritchard, N; Poulsen, P; Tabaksblat, EM; Weber, B; Worm, E; Pryor, D; Chu, J; Hardcastle, N; Booth, J; Gebski, V; Wang, T; Keall, P |
| 2018-10-23 | TROG 15.03 phase II clinical trial of Focal Ablative STereotactic Radiosurgery for Cancers of the Kidney - FASTRACK II 11 Medical and Health Sciences 1103 Clinical Sciences 11 Medical and Health Sciences 1112 Oncology and Carcinogenesis | Siva, S; Chesson, B; Bressel, M; Pryor, D; Higgs, B; Reynolds, HM; Hardcastle, N; Montgomery, R; Vanneste, B; Khoo, V; Ruben, J; Lau, E; Hofman, MS; De Abreu Lourenco, R; Sridharan, S; Brook, NR; Martin, J; Lawrentschuk, N; Kron, T; Foroudi, F |
